| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/25/2002 | US20020049243 Pyrrolidine derivatives |
| 04/25/2002 | US20020049239 Novel indole and benzothiazole derivatives |
| 04/25/2002 | US20020049238 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/25/2002 | US20020049233 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049224 Alpha v integrin receptor antagonists |
| 04/25/2002 | US20020049222 Cyclopentyl modulators of chemokine receptor activity |
| 04/25/2002 | US20020049215 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/25/2002 | US20020049212 Benzimidazole compounds and salts containing piperidine ring are useful in treatment or prevention or medical conditions selected from pain, and inflammatoy diseases; analgesics |
| 04/25/2002 | US20020049207 Nitrogen containing heterobicyclic compounds for treating disorders manifesting hypersecretion of corticotropin releasign factor(CRF) in a warm-blooded animals, such as stroke |
| 04/25/2002 | US20020049196 Hexahydro-pyrazolo-(4,3-c)pyridine derivatives useful for increasing the endogenous production or release of growth hormone in a human or other animal, thus treat or prevent osteoporosis |
| 04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
| 04/25/2002 | US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers. |
| 04/25/2002 | US20020049182 Administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies. |
| 04/25/2002 | US20020049158 Increasing bioavailability of a drug which is not readily absorbed in the digestive tract |
| 04/25/2002 | US20020049155 Cobalamin compounds useful as cardiovascular agents and as imaging agents |
| 04/25/2002 | US20020048801 Peptide with enzymatic activity; for use as diagnostic tools in detecting cancer and cardiovascular and liver disorders |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048785 Novel polypeptides within the tumor necrosis factor receptor superfamily and uses therefor |
| 04/25/2002 | US20020048599 Method for increasing tissue perfusion by co-administration of an agent that increases cGMP synthesis and an agent that inhibits cGMP degradation |
| 04/25/2002 | US20020048571 Chimeric polypeptides of serum albumin and uses related thereto |
| 04/25/2002 | DE10051321A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are potent neurokinin antagonists, useful e.g. for treating allergic, inflammatory or central nervous system diseases |
| 04/25/2002 | DE10051320A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are neurokinin antagonists having a long duration of action, useful e.g. for treating allergic, inflammatory or central nervous system diseases |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2453140A1 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/25/2002 | CA2426604A1 Compounds with high monoamine transporter affinity |
| 04/25/2002 | CA2426592A1 Combination of statins and sorbitol dehydrogenase inhibitors |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426381A1 Cell damage inhibitor |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | CA2426120A1 Combination use of acetylcholinesterase inhibitors and gabaa inverse agonists for the treatment of cognitive disorders |
| 04/25/2002 | CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425804A1 Urotensin-ii agonists and antagonists |
| 04/25/2002 | CA2425221A1 Protein c or activated protein c-like molecules |
| 04/25/2002 | CA2424729A1 Estrogen receptor modulators |
| 04/25/2002 | CA2424726A1 Estrogen receptor modulators |
| 04/25/2002 | CA2424689A1 Orally active salts with tyrosine kinase activity |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/25/2002 | CA2423469A1 Methods and products related to pulmonary delivery of polysaccharides |
| 04/25/2002 | CA2421597A1 Cycloalkylfluorosulfonamide derivatives |
| 04/25/2002 | CA2420994A1 Method of treating stroke |
| 04/24/2002 | EP1199372A2 Polymorphisms in the human P2X7 gene |
| 04/24/2002 | EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 04/24/2002 | EP1199076A2 Medicament containing tocotrienol as active component |
| 04/24/2002 | EP1199075A2 Use of vitamine E metabolites alpha-CEHC and gamma-CEHC as antioxidants |
| 04/24/2002 | EP1199074A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 04/24/2002 | EP1199071A2 Use of an estrogen agonist/antagonist for improving vascular health |
| 04/24/2002 | EP1199067A2 Prophylactic use of N-Methyl-D-Aspartate (NMDA) antagonists |
| 04/24/2002 | EP1198589A1 Tenascin-c nucleic acid ligands |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 04/24/2002 | EP1198479A1 Neovascular-targeted immunoconjugates |
| 04/24/2002 | EP1198477A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 04/24/2002 | EP1198464A1 8-PHENYL-6,9-DIHYDRO- 1,2,4]TRIAZOLO 3,4- i i /i ]PURIN-5-ONE DERIVATIVES |
| 04/24/2002 | EP1198463A2 Compounds for use in treatment of neurological disorders |
| 04/24/2002 | EP1198456A2 Potassium channel openers |
| 04/24/2002 | EP1198255A1 Identification of compounds that modify transcriptional responses to hypoxia |
| 04/24/2002 | EP1198246A2 Methods for preventing or attenuating pathoangiogenic conditions by using the gbs-toxin (cm101) receptor as a vaccine |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | EP1198240A2 Tissue regenerating agent |
| 04/24/2002 | EP1082125B1 Pharmaceutical or cosmetical use of an extract of ruscus aculeatus for the treatment of hair disorders |
| 04/24/2002 | EP0863911B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/24/2002 | CN1346368A Potassium channel interactors and uses therefor |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/24/2002 | CN1346358A Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
| 04/24/2002 | CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 04/24/2002 | CN1346352A 1-4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 04/24/2002 | CN1346351A 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
| 04/24/2002 | CN1346343A 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 04/24/2002 | CN1346292A Treatment of thrombosis by combined useof a factor Xa inhibitor and aspirin, tissue plasminogen activator (TPA) a gpII/IIIA antagonist, low molecular weight heparin or heparin |
| 04/24/2002 | CN1346283A External coated chewing gum products |
| 04/24/2002 | CN1346275A Treatment of accidental extravasation of anthracyclines |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1345727A Aqueous soluble steroid compound alkaloid salt, preparation process and medicinal composition containing same |
| 04/24/2002 | CN1345602A Indication of one group cell factor |
| 04/24/2002 | CN1083452C Pyrido (2,3-d) pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
| 04/24/2002 | CN1083443C 吲哚衍生物 Indole derivatives |
| 04/24/2002 | CN1083267C Compositions of cartaegus species, medicaments and their use |
| 04/24/2002 | CA2359606A1 Cysteine/glycine rich peptides |
| 04/23/2002 | US6376672 Restenosis; vision defects; cardiovascular disorders; kidney dieases |
| 04/23/2002 | US6376666 2-mercaptobenzimidazole derivatives possessing pharmacological activity |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376653 Tie2 antagonist antibodies |
| 04/23/2002 | US6376540 Furan nitrone compounds |
| 04/23/2002 | US6376539 Antiischemic agents, central nervous system disorders |
| 04/23/2002 | US6376532 Neurotransmitter |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?) |
| 04/23/2002 | US6376512 Therapeutic uses of quinoline derivatives |